73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
World-first use of base-edited CAR T cells to treat resistant leukemia

World-first use of base-edited CAR T cells to treat resistant leukemia

byUniversity College LondonCredit: Unsplash/CC0 Public DomainA patient with relapsed T cell leukaemia has been given base-edited T-cells in a world-first use of a base-edited cell therapy, in a

World-first use of base-edited CAR T cells to treat resistant leukemia

byUniversity College LondonCredit: Unsplash/CC0 Public DomainA patient with relapsed T cell leukaemia has been given base-edited T-cells in a world-first use of a base-edited cell therapy, in a
3-D mammography detected 34% more breast cancers in screening

3-D mammography detected 34% more breast cancers in screening

byLund UniversityUsing breast tomosynthesis (3D screening) in the image to the left (one of about 50 thin cross-sectional image slices of the breast), you can see an approximately 1 cm-large tum

3-D mammography detected 34% more breast cancers in screening

byLund UniversityUsing breast tomosynthesis (3D screening) in the image to the left (one of about 50 thin cross-sectional image slices of the breast), you can see an approximately 1 cm-large tum
Scientists develop powerful AI algorithm to gain new insights into deadly glioblastoma

Scientists develop powerful AI algorithm to gain new insights into deadly glioblastoma

by Sylvester Comprehensive Cancer CenterThe SPHINKS network for the precision targeting of master kinases in glioblastoma. Credit: Antonio Iavarone, M.D.Scientists at Sylvester Comprehensive Cancer Ce

Scientists develop powerful AI algorithm to gain new insights into deadly glioblastoma

by Sylvester Comprehensive Cancer CenterThe SPHINKS network for the precision targeting of master kinases in glioblastoma. Credit: Antonio Iavarone, M.D.Scientists at Sylvester Comprehensive Cancer Ce
Pathogenesis to management of hepatocellular carcinoma

Pathogenesis to management of hepatocellular carcinoma

by Impact JournalsMolecular pathways and targeted therapeutics in hepatocellular carcinoma. Abbreviations: APC: antigen presenting cell; AXL is a cell surface receptor tyrosine kinase, part of the TAM

Pathogenesis to management of hepatocellular carcinoma

by Impact JournalsMolecular pathways and targeted therapeutics in hepatocellular carcinoma. Abbreviations: APC: antigen presenting cell; AXL is a cell surface receptor tyrosine kinase, part of the TAM
Radiation therapy cuts low risk of recurrence in half for patients with 'good risk' breast cancer

Radiation therapy cuts low risk of recurrence in half for patients with 'good risk' breast cancer

by NRG OncologyA subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiationtherapy

Radiation therapy cuts low risk of recurrence in half for patients with 'good risk' breast cancer

by NRG OncologyA subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiationtherapy
Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe next-generation selective estrogen receptor degrader (SERD) camizestrant improved progression-free survival, compar

Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe next-generation selective estrogen receptor degrader (SERD) camizestrant improved progression-free survival, compar
NELSON trial protocol more sensitive than NLST and may increase the benefits of lung cancer screening

NELSON trial protocol more sensitive than NLST and may increase the benefits of lung cancer screening

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe protocol used to screen and detect lung cancer in the NELSON Trial is more sensitive than the protocol use

NELSON trial protocol more sensitive than NLST and may increase the benefits of lung cancer screening

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe protocol used to screen and detect lung cancer in the NELSON Trial is more sensitive than the protocol use
Researching a new treatment option for severe blood disorders of the bone marrow

Researching a new treatment option for severe blood disorders of the bone marrow

by Anne Grimm,Leipzig UniversityCredit: CC0 Public DomainWhen people develop myelodysplastic neoplasms (MDS), the healthy maturation of blood cells is impaired. Severe forms, known as higher-ris

Researching a new treatment option for severe blood disorders of the bone marrow

by Anne Grimm,Leipzig UniversityCredit: CC0 Public DomainWhen people develop myelodysplastic neoplasms (MDS), the healthy maturation of blood cells is impaired. Severe forms, known as higher-ris
Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

by Garth Sundem,CU Anschutz Medical CampusRobert C. Doebele, MD, PhD. Credit: CU Anschutz Medical CampusPooled analysis of three phase 1 and 2 clinical trials published online ahead of print in

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

by Garth Sundem,CU Anschutz Medical CampusRobert C. Doebele, MD, PhD. Credit: CU Anschutz Medical CampusPooled analysis of three phase 1 and 2 clinical trials published online ahead of print in
Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati
Scientists uncover novel DNA repair mechanism for key cancer target

Scientists uncover novel DNA repair mechanism for key cancer target

byThe Francis Crick InstituteGraphical Abstract. Credit:Molecular Cell(2022). DOI: 10.1016/j.molcel.2022.11.008Scientists at the Francis Crick Institute, in collaboration with Artios

Scientists uncover novel DNA repair mechanism for key cancer target

byThe Francis Crick InstituteGraphical Abstract. Credit:Molecular Cell(2022). DOI: 10.1016/j.molcel.2022.11.008Scientists at the Francis Crick Institute, in collaboration with Artios
How cancer cells move and metastasize is influenced by the fluids surrounding them

How cancer cells move and metastasize is influenced by the fluids surrounding them

by Yizeng Li,The ConversationCredit: CC0 Public DomainCell migration, or how cells move in the body, is essential to both normal body function and disease progression. Cell movement is what allo

How cancer cells move and metastasize is influenced by the fluids surrounding them

by Yizeng Li,The ConversationCredit: CC0 Public DomainCell migration, or how cells move in the body, is essential to both normal body function and disease progression. Cell movement is what allo